NewEdge Advisors LLC Has $19.88 Million Stake in CME Group Inc. $CME

NewEdge Advisors LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 12.9% during the first quarter, Holdings Channel.com reports. The institutional investor owned 67,317 shares of the financial services provider’s stock after acquiring an additional 7,672 shares during the quarter. NewEdge Advisors LLC’s holdings in CME Group were worth $19,882,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. First Nebraska Trust Co bought a new stake in shares of CME Group in the 1st quarter valued at about $577,000. Keel Point LLC boosted its stake in CME Group by 3.6% during the 1st quarter. Keel Point LLC now owns 1,510 shares of the financial services provider’s stock worth $446,000 after acquiring an additional 52 shares during the last quarter. Groupama Asset Managment boosted its stake in CME Group by 16.2% during the 1st quarter. Groupama Asset Managment now owns 268,871 shares of the financial services provider’s stock worth $79,411,000 after acquiring an additional 37,526 shares during the last quarter. Segall Bryant & Hamill LLC acquired a new position in CME Group during the first quarter valued at approximately $2,810,000. Finally, BankChampaign National Association acquired a new position in CME Group during the first quarter valued at approximately $275,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Price Performance

CME stock opened at $263.66 on Friday. The stock has a 50-day moving average price of $249.24 and a two-hundred day moving average price of $280.78. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock has a market cap of $94.81 billion, a PE ratio of 22.36, a price-to-earnings-growth ratio of 3.08 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.96 earnings per share. Equities analysts forecast that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. CME Group’s dividend payout ratio is 44.11%.

Wall Street Analyst Weigh In

CME has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Morgan Stanley raised their price objective on CME Group from $324.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, July 23rd. UBS Group lowered their price target on CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a report on Monday, July 6th. The Goldman Sachs Group dropped their price target on CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research report on Tuesday, June 30th. Finally, JPMorgan Chase & Co. boosted their price objective on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research report on Thursday, July 23rd. Eleven investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $291.81.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard bought 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the acquisition, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.